Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on June 9, 2003. The report serves to disclose financial results for the second quarter of fiscal year 2003 via a press release attached as Exhibit 99.1. The filing is made pursuant to Regulation FD and Item 12 of the Securities Exchange Act of 1934.
Key Financial Metrics
The provided text is a cover document and exhibit index; it does not contain the actual financial data from the attached press release (Exhibit 99.1). Consequently, the filing text does not provide clear values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Positions
Material Changes
The filing text does not provide specific data to compare current period performance against the prior comparable period. Material changes in financial condition or results of operations are referenced only as being contained within the attached Exhibit 99.1.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information is furnished under Regulation FD and should not be deemed "filed" for purposes of the Securities Exchange Act of 1934, nor incorporated by reference into other filings.
Investor Verification Checklist
- Entity Verification: Confirm the registrant is Landec Corporation, not Lifecore Biomedical, Inc.
- Exhibit Retrieval: Locate and review Exhibit 99.1 (Press Release dated June 9, 2003) to obtain actual Q2 2003 financial figures.
- Filing Status: Note that the content of this 8-K is not deemed "filed" under the Exchange Act and is not incorporated by reference into other SEC filings.
- Period Confirmation: Verify that the financial results pertain specifically to the second quarter of fiscal year 2003.